Navigating The Regulatory Maze In Emerging Markets – It’s An Art Too
Executive Summary
Emerging markets have become commercially more relevant for pharma, but dealing with 100-plus regulatory bodies and their varied requirements may require more than just precise science, an industry expert tells a conference in India.